Effectiveness and safety of a 1-L polyethylene glycol and ascorbic acid preparation for colonoscopy in routine clinical practice in Spain.

IF 2.7 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Revista Espanola De Enfermedades Digestivas Pub Date : 2024-11-01 DOI:10.17235/reed.2024.10426/2024
Vicente Lorenzo-Zúñiga García, Fernando Sábado Martí, Miguel Ángel Pantaleón Sánchez, Salvador Machlab Mashlab, David Carral Martínez, Blas José Gómez Rodríguez, Antonio López Cano, Sarbelio Rodríguez Muñoz, Elena Pérez Arellano, Carmen Turbi Disla, José Miguel Esteban López-Jamar
{"title":"Effectiveness and safety of a 1-L polyethylene glycol and ascorbic acid preparation for colonoscopy in routine clinical practice in Spain.","authors":"Vicente Lorenzo-Zúñiga García, Fernando Sábado Martí, Miguel Ángel Pantaleón Sánchez, Salvador Machlab Mashlab, David Carral Martínez, Blas José Gómez Rodríguez, Antonio López Cano, Sarbelio Rodríguez Muñoz, Elena Pérez Arellano, Carmen Turbi Disla, José Miguel Esteban López-Jamar","doi":"10.17235/reed.2024.10426/2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>large clinical trials and small real-world studies show that a 1-L polyethylene glycol and ascorbic acid solution (1-L PEG-ASC) is an effective and safe bowel preparation for colonoscopy. Here, the effectiveness and safety of 1-L PEG-ASC was evaluated in a large cohort of patients in routine clinical practice in Spain.</p><p><strong>Methods: </strong>a sub-analysis was performed in an observational, multicenter, retrospective study assessing the effectiveness and safety of 1-L PEG-ASC in adult patients undergoing a colonoscopy at ten centers in Spain. Cleansing quality was assessed with the Boston Bowel Preparation Scale, scores ≥ 6 with all segmental scores ≥ 2 were considered as adequate colon cleansing, and high-quality was considered as cleansing ≥ 8 or = 3 in the right colon. Polyp and adenoma detection rates, and adverse events were also assessed.</p><p><strong>Results: </strong>data were collected from 7,160 patients; 48.3 % were males, mean age was 58.0 and 33.6 % were ≥ 65 years old. Adequate overall bowel cleansing was achieved in 95.6 % of patients (95 % CI: 95.1-96.0 %), high quality cleansing in 74.4 % (95 % CI: 73.4-75.4 %) and high-quality right colon cleansing in 66.0 % (95 % CI: 64.9-67.1). The adequate overall cleansing rate was 97.0 % with a split-dose and 94.0 % with same-day regimen (p < 0.0001), and high-quality right colon cleansing was 69.0 % and 62.5 % (p < 0.0001), respectively. Colonoscopy was completed in 97.2 % of cases. A multivariate regression analysis revealed that an overnight split-dose regimen and age < 65 years were independent predictors of adequate bowel cleansing of the overall colon, age < 65 years and female gender were independent predictors of high quality (HQ) cleansing of the overall colon, and the three covariates were independent predictors of HQ cleansing of the right colon. At least one adverse event was experienced by 3.3 % of participants, with nausea (1.5 %) and vomiting (1.2 %) being the most frequent.</p><p><strong>Conclusion: </strong>this sub-analysis confirmed 1-L PEG-ASC to be an effective and safe bowel cleansing preparation in a real world setting in Spain.</p>","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":"116 ","pages":"599-605"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Enfermedades Digestivas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17235/reed.2024.10426/2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: large clinical trials and small real-world studies show that a 1-L polyethylene glycol and ascorbic acid solution (1-L PEG-ASC) is an effective and safe bowel preparation for colonoscopy. Here, the effectiveness and safety of 1-L PEG-ASC was evaluated in a large cohort of patients in routine clinical practice in Spain.

Methods: a sub-analysis was performed in an observational, multicenter, retrospective study assessing the effectiveness and safety of 1-L PEG-ASC in adult patients undergoing a colonoscopy at ten centers in Spain. Cleansing quality was assessed with the Boston Bowel Preparation Scale, scores ≥ 6 with all segmental scores ≥ 2 were considered as adequate colon cleansing, and high-quality was considered as cleansing ≥ 8 or = 3 in the right colon. Polyp and adenoma detection rates, and adverse events were also assessed.

Results: data were collected from 7,160 patients; 48.3 % were males, mean age was 58.0 and 33.6 % were ≥ 65 years old. Adequate overall bowel cleansing was achieved in 95.6 % of patients (95 % CI: 95.1-96.0 %), high quality cleansing in 74.4 % (95 % CI: 73.4-75.4 %) and high-quality right colon cleansing in 66.0 % (95 % CI: 64.9-67.1). The adequate overall cleansing rate was 97.0 % with a split-dose and 94.0 % with same-day regimen (p < 0.0001), and high-quality right colon cleansing was 69.0 % and 62.5 % (p < 0.0001), respectively. Colonoscopy was completed in 97.2 % of cases. A multivariate regression analysis revealed that an overnight split-dose regimen and age < 65 years were independent predictors of adequate bowel cleansing of the overall colon, age < 65 years and female gender were independent predictors of high quality (HQ) cleansing of the overall colon, and the three covariates were independent predictors of HQ cleansing of the right colon. At least one adverse event was experienced by 3.3 % of participants, with nausea (1.5 %) and vomiting (1.2 %) being the most frequent.

Conclusion: this sub-analysis confirmed 1-L PEG-ASC to be an effective and safe bowel cleansing preparation in a real world setting in Spain.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在西班牙常规临床实践中,用于结肠镜检查的 1 升聚乙二醇和抗坏血酸制剂的有效性和安全性。
背景和目的:大型临床试验和小型实际研究表明,1 升聚乙二醇和抗坏血酸溶液(1 升 PEG-ASC)是结肠镜检查前有效、安全的肠道准备。在此,我们对西班牙常规临床实践中的一大批患者进行了 1 升 PEG-ASC 的有效性和安全性评估:在一项观察性、多中心、回顾性研究中进行了一项子分析,评估了在西班牙 10 个中心接受结肠镜检查的成年患者使用 1L PEG-ASC 的有效性和安全性。清洁质量采用波士顿肠道准备量表(Boston Bowel Preparation Scale)进行评估,得分≥6 分且所有节段得分≥2 分视为结肠充分清洁,右侧结肠清洁度≥8 分或=3 分视为高质量清洁。此外,还对息肉和腺瘤的检出率以及不良事件进行了评估:共收集了 7160 名患者的数据:48.3%为男性;平均年龄58.0岁,33.6%≥65岁。95.6%的患者实现了充分的总体肠道清洁(95% CI 95.1%-96.0%),74.4%的患者实现了高质量的清洁(95% CI 73.4%-75.4%),66.0%的患者实现了高质量的右结肠清洁(95% CI 64.9-67.1)。分次给药的充分总体清洁率为 97.0%,当天给药的充分总体清洁率为 94.0%:这项子分析证实,在西班牙的实际环境中,1L PEG-ASC 是一种有效、安全的肠道清洁制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.00
自引率
25.00%
发文量
400
审稿时长
6-12 weeks
期刊介绍: La Revista Española de Enfermedades Digestivas, Órgano Oficial de la Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Endoscopia Digestiva (SEED) y Asociación Española de Ecografía Digestiva (AEED), publica artículos originales, editoriales, revisiones, casos clínicos, cartas al director, imágenes en patología digestiva, y otros artículos especiales sobre todos los aspectos relativos a las enfermedades digestivas.
期刊最新文献
A key aspect of randomized controlled trials: allocation concealment. A novel and challenging EUS-guided bridging technique for hilar cholangiocarcinoma (Bismuth IV) after total gastrectomy. Acceptable number of cholangioscopy-guided biopsies for diagnosing perihilar cholangiocarcinoma. Autochthonous amebiasis in Spain. Duodenal perforation due to biliary plastic stent. Endoscopic management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1